Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
276
Views
10
CrossRef citations to date
0
Altmetric
Original Research

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline

Marjan Kerkhof1 Observational & Pragmatic Research Institute Pte Ltd, Singapore, SingaporeORCID Iconhttps://orcid.org/0000-0002-3823-1061
ORCID Icon,
Jaco Voorham1 Observational & Pragmatic Research Institute Pte Ltd, Singapore, SingaporeORCID Iconhttps://orcid.org/0000-0001-9002-1865
ORCID Icon,
Paul Dorinsky2 AstraZeneca, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0002-4814-0657
ORCID Icon,
Claudia Cabrera3 AstraZeneca, Mölndal, Sweden;4 Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
,
Patrick Darken5 AstraZeneca, Morristown, NJ, USA
,
Janwillem W H Kocks1 Observational & Pragmatic Research Institute Pte Ltd, Singapore, Singapore;6 General Practitioners Research Institute, Groningen, The Netherlands
,
Mohsen Sadatsafavi7 Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, University of British Columbia, Vancouver, BC, Canada;8 Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, BC, CanadaORCID Iconhttps://orcid.org/0000-0002-0419-7862
ORCID Icon,
Don D Sin7 Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, University of British Columbia, Vancouver, BC, Canada;8 Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, BC, CanadaORCID Iconhttps://orcid.org/0000-0002-0756-6643
ORCID Icon,
Victoria Carter1 Observational & Pragmatic Research Institute Pte Ltd, Singapore, Singapore
&
David B Price1 Observational & Pragmatic Research Institute Pte Ltd, Singapore, Singapore;9 Academic Primary Care, University of Aberdeen, Aberdeen, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9728-9992
ORCID Icon show all
Pages 1909-1918 | Published online: 06 Aug 2020

References

  • Global strategy for the diagnosis, management, and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 Report. Available from: http://www.Goldcopd.Org/. Accessed 2 2020.
  • YeattsKB, LippmannSJ, WallerAE, et al. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest. 2013;144(3):784–793. doi:10.1378/chest.12-189923579283
  • SinghD, D’UrzoAD, DonohueJF, KerwinEM. Weighing the evidence for pharmaco-logical treatment interventions in mild COPD; a narrative perspective. Respir Res. 2019;20(1):141. doi:10.1186/s12931-019-1108-931286970
  • DransfieldMT, KunisakiKM, StrandMJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017;195(3):324–330. doi:10.1164/rccm.201605-1014OC27556408
  • TantucciC, ModinaD. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99. doi:10.2147/COPD.S2748022371650
  • BhattSP, SolerX, WangX, et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(2):178–184. doi:10.1164/rccm.201511-2219OC26808615
  • Optimum Patient Care Research Database (OPCRD). Available from: http://Optimumpatientcare.Org/Opcrd/. Accessed 2 2020.
  • QuintJK, MullerovaH, DiSantostefanoRL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014;4(7):e005540. doi:10.1136/bmjopen-2014-005540
  • ZafariZ, SinDD, PostmaDS, et al. Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. CMAJ. 2016;188(14):1004–1011. doi:10.1503/cmaj.15148327486205
  • VestboJ, AndersonJA, BrookRD, et al. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet. 2016;387(10030):1817–1826. doi:10.1016/S0140-6736(16)30069-127203508
  • CelliBR, ThomasNE, AndersonJA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338. doi:10.1164/rccm.200712-1869OC18511702
  • DonaldsonGC, SeemungalTA, BhowmikA, WedzichaJA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.84712324669
  • MakrisD, MoschandreasJ, DamianakiA, et al. Exacerbations and lung function de-cline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101(6):1305–1312. doi:10.1016/j.rmed.2006.10.01217112715
  • HalpinDMG, DecramerM, CelliB, KestenS, LiuD, TashkinDP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:653–661. doi:10.2147/COPD.S3418623055714
  • HalpinDM, KerkhofM, SorianoJB, MikkelsenH, PriceDB. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir Res. 2016;17(1):120. doi:10.1186/s12931-016-0433-527663386
  • KruisAL, StällbergB, JonesRCM, et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD Studies: an UNLOCK validation study. PLoS One. 2014;9(3):e90145. doi:10.1371/journal.pone.009014524598945
  • TraversJ, MarshS, CaldwellB, et al. External validity of randomized controlled trials in COPD. Respir Med. 2007;101(6):1313–1320. doi:10.1016/j.rmed.2006.10.01117113277
  • HerlandK, AkselsenJP, SkjonsbergOH, BjermerL. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med. 2005;99(1):11–19. doi:10.1016/j.rmed.2004.03.02615672843
  • StrongM, SouthG, CarlisleR. The UK quality and outcomes framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK. BMC Health Serv Res. 2009;9:108. doi:10.1186/1472-6963-9-10819558719
  • WellsBJ, ChaginKM, NowackiAS, KattanMW. Strategies for handling missing data in electronic health record derived data. EGEMS. 2013;1(3):1035.25848578
  • van StaaT-P, DysonL, McCannG, et al. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess. 2014;18(43):1–146. doi:10.3310/hta18430
  • KerkhofM, VoorhamJ, DorinskyP, et al. Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax. 2020. doi:10.1136/thoraxjnl-2019-214457

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.